Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 391

Results: 6

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.
Published in:
Science Translational Medicine, 2017, v. 9, n. 391, p. 1, doi. 10.1126/scitranslmed.aal4682
By:
- Kodack, David P.;
- Askoxylakis, Vasileios;
- Ferraro, Gino B.;
- Qing Sheng;
- Badeaux, Mark;
- Goel, Shom;
- Xiaolong Qi;
- Shankaraiah, Ram;
- Cao, Z. Alexander;
- Ramjiawan, Rakesh R.;
- Bezwada, Divya;
- Patel, Bhushankumar;
- Yongchul Song;
- Costa, Carlotta;
- Naxerova, Kamila;
- Wong, Christina S. F.;
- Kloepper, Jonas;
- Das, Rita;
- Tam, Angela;
- Tanboon, Jantima
Publication type:
Article
Response to comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
Published in:
2017
By:
- Xiaoli Zheng;
- Yanqing Liu;
- Qinqin Yu;
- Hua Wang;
- Fuqing Tan;
- Qianying Zhu;
- Lingmin Yuan;
- Huidi Jiang;
- Su Zeng;
- Lushan Yu
Publication type:
Letter to the Editor
Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".
Published in:
2017
By:
- Winter, Stefan;
- Fisel, Pascale;
- Büttner, Florian;
- Nies, Anne T.;
- Stenzl, Arnulf;
- Bedke, Jens;
- Schwab, Matthias;
- Schaeffeler, Elke
Publication type:
Letter to the Editor
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.
Published in:
Science Translational Medicine, 2017, v. 9, n. 391, p. 1, doi. 10.1126/scitranslmed.aal3226
By:
- Yang, Katherine S.;
- Hyungsoon Im;
- Seonki Hong;
- Pergolini, Ilaria;
- del Castillo, Andres Fernandez;
- Rui Wang;
- Clardy, Susan;
- Chen-Han Huang;
- Pille, Craig;
- Ferrone, Soldano;
- Yang, Robert;
- Castro, Cesar M.;
- Hakho Lee;
- del Castillo, Carlos Fernandez;
- Weissleder, Ralph
Publication type:
Article
Bacterial colonization and succession in a newly opened hospital.
Published in:
Science Translational Medicine, 2017, v. 9, n. 391, p. 1, doi. 10.1126/scitranslmed.aah6500
By:
- Lax, Simon;
- Sangwan, Naseer;
- Smith, Daniel;
- Larsen, Peter;
- Handley, Kim M.;
- Richardson, Miles;
- Guyton, Kristina;
- Krezalek, Monika;
- Shogan, Benjamin D.;
- Defazio, Jennifer;
- Flemming, Irma;
- Shakhsheer, Baddr;
- Weber, Stephen;
- Landon, Emily;
- Garcia-Houchins, Sylvia;
- Siegel, Jeffrey;
- Alverdy, John;
- Knight, Rob;
- Stephens, Brent;
- Gilbert, Jack A.
Publication type:
Article
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
Published in:
Science Translational Medicine, 2017, v. 9, n. 391, p. 1, doi. 10.1126/scitranslmed.aaf3962
By:
- Keiko Imamura;
- Yuishin Izumi;
- Akira Watanabe;
- Kayoko Tsukita;
- Knut Woltjen;
- Takuya Yamamoto;
- Akitsu Hotta;
- Takayuki Kondo;
- Shiho Kitaoka;
- Akira Ohta;
- Akito Tanaka;
- Dai Watanabe;
- Mitsuya Morita;
- Hiroshi Takuma;
- Akira Tamaoka;
- Tilo Kunath;
- Selina Wray;
- Hirokazu Furuya;
- Takumi Era;
- Kouki Makioka
Publication type:
Article

Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 391

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Response to comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".

Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin".

Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy.

Bacterial colonization and succession in a newly opened hospital.

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.